Aurothioglucose does not improve alveolarization or elicit sustained Nrf2 activation in C57BL/6 models of bronchopulmonary dysplasia.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  American Journal of Physiology - Lung cellular and Molecular Physiology

• Publication date

  2018-05-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1152/ajplung.00539.2017PMID 29368550PMCID PMC6008122
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Caffeine administration modulates TGF-β signaling but does not attenuate blunted alveolarization in a hyperoxia-based mouse model of bronchopulmonary dysplasia

  2017cited by this paper
• Standardisation of oxygen exposure in the development of mouse models for bronchopulmonary dysplasia

  2017influential reference
• Looking ahead: where to next for animal models of bronchopulmonary dysplasia?

  2016influential reference
• Thioredoxin Reductase Inhibition Attenuates Neonatal Hyperoxic Lung Injury and Enhances Nuclear Factor E2-Related Factor 2 Activation.

  2016cited by this paper
• Regulation of alveolar septation by microRNA-489.

  2016cited by this paper
• Recent advances in the mechanisms of lung alveolarization and the pathogenesis of bronchopulmonary dysplasia.

  2015cited by this paper
• Association of Nrf2 Polymorphism Haplotypes with Acute Lung Injury Phenotypes in Inbred Strains of Mice

  2015cited by this paper
• The Thioredoxin System in Neonatal Lung Disease

  2014cited by this paper
• The Thioredoxin Reductase-1 Inhibitor Aurothioglucose Attenuates Lung Injury and Improves Survival in a Murine Model of Acute Respiratory Distress Syndrome

  2014cited by this paper
• Genome‐wide association mapping of acute lung injury in neonatal inbred mice

  2014cited by this paper
• Thioredoxin Reductase Inhibition Elicits Nrf2-Mediated Responses in Clara Cells: Implications for Oxidant-Induced Lung Injury

  2012cited by this paper
• Targeted Deletion of Nrf2 Impairs Lung Development and Oxidant Injury in Neonatal Mice

  2012cited by this paper
• NRF2 targeting: a promising therapeutic strategy in chronic obstructive pulmonary disease.

  2011cited by this paper
• Future applications of antioxidants in premature infants

  2011cited by this paper
• Deficits in lung alveolarization and function after systemic maternal inflammation and neonatal hyperoxia exposure.

  2010cited by this paper
• Nrf2 protects against airway disorders.

  2010cited by this paper
• The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative Stress*

  2009cited by this paper
• Highly active dimeric and low-activity tetrameric forms of selenium-containing rat thioredoxin reductase 1.

  2009cited by this paper
• Nrf2 increases survival and attenuates alveolar growth inhibition in neonatal mice exposed to hyperoxia.

  2009cited by this paper
• The triterpenoid CDDO-imidazolide confers potent protection against hyperoxic acute lung injury in mice.

  2009cited by this paper
• Oxidative Stress and Antioxidants in the Pathogenesis of Pulmonary Fibrosis: A Potential Role for Nrf2

  2008cited by this paper
• Thioredoxin-related mechanisms in hyperoxic lung injury in mice.

  2007cited by this paper
• Role of Toll-like receptor 4 in hyperoxia-induced lung inflammation in mice

  2007cited by this paper
• Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway.

  2007cited by this paper
• Interactions of Nitroaromatic Compounds with the Mammalian Selenoprotein Thioredoxin Reductase and the Relation to Induction of Apoptosis in Human Cancer Cells*

  2006cited by this paper
• Genetic basis of murine responses to hyperoxia-induced lung injury

  2006cited by this paper
• Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia.

  2005cited by this paper
• Linkage analysis of susceptibility to hyperoxia. Nrf2 is a candidate gene.

  2002cited by this paper
• Antioxidant vitamin levels in term and preterm infants and their relation to maternal vitamin status.

  2002cited by this paper
• Preparation and assay of mammalian thioredoxin and thioredoxin reductase.

  1999cited by this paper
• Glutathione metabolism in newborns: Evidence for glutathione deficiency in plasma, bronchoalveolar lavage fluid, and lymphocytes in prematures

  1995cited by this paper
• Oxidant Stress Responses in Premature Infants during Exposure to Hyperoxia

  1993cited by this paper

• Selenium Deficiency Exacerbates Hyperoxia-Induced Lung Injury in Newborn C3H/HeN Mice

  2024cites this paper
• Neonatal Selenium Deficiency Decreases Selenoproteins in the Lung and Impairs Pulmonary Alveolar Development

  2022cites this paper
• Transcriptomic-Metabolomic Profiling in Mouse Lung Tissues Reveals Sex- and Strain-Based Differences

  2022cites this paper
• Human-induced pluripotent stem cell-derived cardiomyocytes, 3D cardiac structures, and heart-on-a-chip as tools for drug research

  2021cites this paper
• Club Cell Heme Oxygenase-1 Deletion: Effects in Hyperoxia-Exposed Adult Mice

  2020cites this paper
• Selenium-independent antioxidant and anti-inflammatory effects of thioredoxin reductase inhibition in alveolar macrophages.

  2020cites this paper
• Preconditioning the immature lung with enhanced Nrf2 activity protects against oxidant-induced hypoalveolarization in mice

  2020cites this paper
• Glutathione reductase deficiency alters lung development and hyperoxic responses in neonatal mice

  2020cites this paper
• Aurothioglucose Enhances Pro-Angiogenic Pathway Activation in Lungs from Room Air and Hyperoxia-exposed Newborn Mice.

  2020cites this paper
• Pediatric Pulmonology

  2019influential citation
• Recent advances in our understanding of the mechanisms of lung alveolarization and bronchopulmonary dysplasia.

  2019cites this paper
• Role of Nrf2 and Its Activators in Respiratory Diseases

  2019cites this paper